P
US5128318AExpiredUtilityPatentIndex 96

Reconstituted HDL particles and uses thereof

Assignee: ROGOSIN INSTPriority: May 20, 1987Filed: Oct 27, 1988Granted: Jul 7, 1992
Est. expiryMay 20, 2007(expired)· nominal 20-yr term from priority
Inventors:LEVINE DANIEL MSIMON SANFORD RGORDON BRUCE RPARKER THOMAS SSAAL STUART DRUBIN ALBERT L
A61K 31/00A61K 9/1275Y10S436/829
96
PatentIndex Score
155
Cited by
17
References
7
Claims

Abstract

A reconstituted high density lipoprotein containing particle is disclosed. The particle is useful in removing excess lipid soluble material from a subject to which it is administered, as well as in delivery of lipid soluble pharmaceuticals to subjects or patients.

Claims

exact text as granted — not AI-modified
We claim: 
     
       1. Method for treating a subject for endotoxin caused toxicity comprising administering to said subject an amount of a reconstituted, cholesterol free particle which contains (i) an HDL associated apolipoprotein and (ii) a lipid in which the endotoxin causing said toxicity is soluble sufficient to alleviate toxicity caused by said endotoxin. 
     
     
       2. Method for treating a subject for endotoxin caused toxicity comprising administering to said subject an amount of a reconstituted particle containing (i) cholesterol, (ii) an HDL associated apolipoprotein, and (iii) a lipid in which endotoxin causing said toxicity is soluble, in an amount sufficient to alleviate toxicity caused by said endotoxin. 
     
     
       3. Method of claim 1, wherein said reconstituted particle consists of said high density lipoprotein associated apolipoprotein associated apolipoprotein is apolipoprotein AI. 
     
     
       4. Method of claim 1, wherein said high density lipoprotein associated apolipoprotein is apolipoprotein AII. 
     
     
       5. Method of claim 1, wherein said high density lipoprotein associated apolipoprotein is apolipoprotein AII. 
     
     
       6. Method of claim 2, wherein said high density lipoprotein associated apolipoprotein is apolipoprotein AI. 
     
     
       7. Method of claim 2, wherein said high density lipoprotein associated apolipoprotein is apolipoprotein AII.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.